Related Experiment Video

Updated: Mar 19, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

8.1K

microRNA-497 Modulates Breast Cancer Cell Proliferation, Invasion, and Survival by Targeting SMAD7

Jingjing Liu1,2,3, Yang Zhou1,2,3, Zhendong Shi1,2,3

  • 11 Third Department of Breast Cancer, China Tianjin Breast Cancer Prevention, Treatment and Research Center, Tianjin Medical University Cancer Institute and Hospital , National Clinical Research Center of Cancer, Tianjin, People's Republic of China .

DNA and Cell Biology
|June 16, 2016
PubMed

Insights

MicroRNA-497 (miR-497) suppresses breast cancer growth by targeting SMAD7. Upregulating miR-497 inhibits tumor progression and offers a potential therapeutic strategy for HER2-positive and triple-negative breast cancer (TNBC).

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Genetics

Background:

  • SMAD7, an inhibitor of TGF-β signaling, has a complex role in breast cancer, potentially promoting metastasis.
  • Limited research exists on SMAD7's function beyond metastasis in breast cancer.
  • MicroRNAs (miRNAs) are key regulators of gene expression implicated in various cancers.

Purpose of the Study:

  • To investigate the regulatory relationship between miR-497 and SMAD7 in breast cancer.
  • To elucidate the functional role of miR-497 in breast cancer cell proliferation and invasion.
  • To assess the therapeutic potential of miR-497 in preclinical breast cancer models.

Main Methods:

  • Bioinformatics analysis to predict miR-497 binding sites on SMAD7 mRNA.
  • Reporter gene assays to validate the interaction between miR-497 and SMAD7.
  • In vitro cell culture experiments (MTT, invasion assays, flow cytometry) to assess miR-497's effects on breast cancer cells.
  • In vivo studies using orthotopic nude mouse models to evaluate tumor growth suppression.
  • Kaplan-Meier survival analysis to correlate miR-497 expression with patient prognosis.

Main Results:

  • A significant inverse correlation was observed between miR-497 and SMAD7 expression in breast cancer tissues.
  • miR-497 directly targets the 3' untranslated region of SMAD7, reducing its expression.
  • Overexpression of miR-497 suppressed breast cancer cell proliferation and invasion, inducing S-phase arrest.
  • In vivo, miR-497 mimics significantly inhibited tumor growth in mouse models.
  • High miR-497 expression correlated with improved patient prognosis, particularly in HER2-positive and triple-negative breast cancer (TNBC).

Conclusions:

  • SMAD7 promotes breast cancer proliferation, and its expression is post-transcriptionally regulated by miR-497.
  • miR-497 acts as a tumor suppressor in breast cancer.
  • miR-497 represents a promising therapeutic target for HER2-positive and TNBC.

More Related Videos

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library08:40

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library

Published on: April 6, 2012

18.1K
Clinicopathological Analysis of miRNA Expression in Breast Cancer Tissues by Using miRNA In Situ Hybridization06:01

Clinicopathological Analysis of miRNA Expression in Breast Cancer Tissues by Using miRNA In Situ Hybridization

Published on: June 7, 2016

7.1K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.5K
MicroRNAs01:22

MicroRNAs

12.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K